npj Vaccines : Impact Factor & More
eISSN: 2059-0105pISSN: 2059-0105
Open AccessShare this on:
Key Metrics
CiteScore 
9.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q1Immunology
SNIP
1.99
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on npj Vaccines
npj Vaccines Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3190 | USD 3490 | GBP 2790 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Sealy Center for Vaccine Development at the University of Texas Medical Branch |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in npj Vaccines ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in npj Vaccines
Scientific synergy between prophylactic and therapeutic HIV vaccines\u2014prevention and cure
- 27 Jul 2026
- NPJ Vaccines
Fraction of viable virus particles in live varicella vaccine influences the profile of immune response.
- 21 Jul 2026
- NPJ vaccines
Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia.
- 20 Jul 2026
- NPJ vaccines
Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis.
- 19 Jul 2026
- NPJ vaccines
Single-cell technologies in mRNA cancer vaccines.
- 18 Jul 2026
- NPJ vaccines
A19Δbpe275 emerges as a safer live attenuated vaccine candidate.
- 16 Jul 2026
- NPJ vaccines
Scientific synergy between prophylactic and therapeutic HIV vaccines\u2014prevention and cure
- 27 Jul 2026
- NPJ Vaccines
Fraction of viable virus particles in live varicella vaccine influences the profile of immune response.
- 21 Jul 2026
- NPJ vaccines
Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia.
- 20 Jul 2026
- NPJ vaccines
Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis.
- 19 Jul 2026
- NPJ vaccines
Single-cell technologies in mRNA cancer vaccines.
- 18 Jul 2026
- NPJ vaccines
A19Δbpe275 emerges as a safer live attenuated vaccine candidate.
- 16 Jul 2026
- NPJ vaccines
FAQs on npj Vaccines
How long has npj Vaccines been actively publishing? 
What is the publishing frequency of npj Vaccines?
How many articles did npj Vaccines publish last year?
What is the eISSN & pISSN for npj Vaccines?
What is Citescore for npj Vaccines?
What is SNIP score for npj Vaccines?
What is the SJR for npj Vaccines?
Who is the publisher of npj Vaccines?
